EGFR Resisters Research Summit(@EGFRSummit) 's Twitter Profileg
EGFR Resisters Research Summit

@EGFRSummit

Summit: Nov 2-4, 2023 • Chicago, IL • @egfrresisters @CEC_onc
Abstract Submission Deadline: CLOSED⏩https://t.co/i1jrgLUVG3

ID:1146064602888855553

calendar_today02-07-2019 14:34:28

721 Tweets

1,1K Followers

151 Following

Dr. Luis E. Raez(@LuisRaezMD) 's Twitter Profile Photo

These are good news for our patients wiht EGFR tumors we need more studies with uncommon mutations and its good to know that osimertinib is an option for them, there is not a lot of experience in compound mutations yet EGFR Resisters EGFR Resisters Research Summit EGFRm NSCLC EGFR Positive UK

account_circle
Dr. Luis E. Raez(@LuisRaezMD) 's Twitter Profile Photo

The U.S. FDA has granted breakthrough therapy designation to sunvozertinib (DZD9008) from Dizal Pharmaceutical as frontline treatment for patients with metastatic NSCLC whose disease harbors an EGFR exon 20 insertion mutation! more options for our EGFR Resisters patients EGFR Resisters Research Summit

account_circle